The test relies on a magnetic nanoparticle linked to fluorescent molecules to detect pancreatic cancer proteins.
HealthDay News — A blood-based test (Freenome) may provide a new option for colorectal cancer (CRC) screening in the average-risk U.S. population, according to a study presented at the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback